Biblio Discovery — Demo Discovery Service

13 results for "Emre Yucel"

Showing 1–13 · 1.49 seconds · RSS

  1. Journal Article

    Association between low-testosterone and kidney stones in US men: The national health and nutrition examination survey 2011–2012

    Emre Yucel; Stacia DeSantis; Mary A. Smith et al.

    Preventive Medicine Reports, Vol. 10 · 2018 · English · DOAJ Scopus

    The purpose of this study was to determine the association between low-testosterone (total testosterone ≤3 ng/mL) and prevalence of kidney stones (KS) in men 20 years and older, and whether this varies by comorbidities, and race/ethnicity, and age. This was a cross-sectional study with data from…

  2. Journal Article

    Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US

    Rafael Fonseca; May Hagiwara; Sumeet Panjabi et al.

    Blood Cancer Journal, Vol. 11 No. 2 · 2021 · English · DOAJ Scopus

    Abstract Effects of disease progression on healthcare resource utilization (HRU) and costs among multiple myeloma (MM) patients with ≥1 line of therapy (LOT) who received their first stem cell transplant (SCT) within 1 year of initial MM diagnosis were estimated using a large US claims database…

  3. Journal Article

    Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating Factor (SEQ-G-CSF)

    Aylin Yucel; Anne Skalicky; Olabimpe Ruth Eseyin et al.

    Journal of Patient-Reported Outcomes, Vol. 5 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Several options for granulocyte colony-stimulating factor (G-CSF) prophylaxis of chemotherapy-induced febrile neutropenia are available to patients worldwide. We have developed a novel patient-reported outcome measure, the Satisfaction and Experience Questionnaire for G-CSF…

  4. Journal Article

    A systematic literature review and (network) meta-analysis of the effectiveness of ceftolozane/tazobactam versus aminoglycosides/polymyxins and ceftazidime/avibactam for treating adult patients with multidrug-resistant Pseudomonas aeruginosa infections

    Hannah Collings; Medi Stone; Maria Chrysostomou et al.

    Antimicrobial Agents and Chemotherapy, Vol. 70 No. 2 · 2026 · English · DOAJ Scopus

    ABSTRACT Multidrug-resistantant (MDR) Pseudomonas aeruginosa is a major public health concern necessitating new antimicrobials. There are new antimicrobials available with activity against MDR-P. aeruginosa, but there is a lack of robust evidence synthesis to guide clinical decision-making for…

  5. Journal Article Full text

    Clinical Outcomes and Healthcare Resource Utilization Results Among Hospitalized Adults with Cystic Fibrosis Treated with Ceftolozane/Tazobactam: A SPECTRA Real-World Subgroup Analysis

    Emre Yucel; Alex Soriano; Florian Thalhammer et al.

    Antibiotics, Vol. 15 No. 8 · 2026 · English · DOAJ Scopus

    Background: Patients with cystic fibrosis (CF) experience recurrent infections requiring repeated antimicrobial therapy, leading to high rates of multidrug-resistant (MDR) Pseudomonas aeruginosa (P. aeruginosa) and contributing substantially to disease-related mortality. Ceftolozane/tazobactam…

  6. Journal Article Full text

    Prescribing Patterns and Clinical Effectiveness of Ceftolozane/Tazobactam for ESBL-Producing Enterobacterales: A SPECTRA Real-World Multi-Country Analysis

    Emre Yucel; Alex Soriano; Florian Thalhammer et al.

    Antibiotics, Vol. 15 No. 5 · 2026 · English · DOAJ Scopus

    Background: Ceftolozane/tazobactam (C/T) has demonstrated activity against ESBL-producing Enterobacterales (ESBL-E) and provides a carbapenem-sparing option. Broader use of C/T alongside other carbapenem/inhibitor combinations may expand therapeutic choices and reduce selection pressure for…

  7. Journal Article Full text

    Prescribing Patterns and Clinical Outcomes of Ceftolozane/Tazobactam by Renal Function and Body Mass Index: A SPECTRA Real-World Multi-Country Analysis

    Emre Yucel; Alex Soriano; Florian Thalhammer et al.

    Antibiotics, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Background: Antimicrobial resistance is a global health crisis associated with high mortality and economic burden. Patients with renal dysfunction and obesity have increased susceptibility to infections and may experience different real-world outcomes, including clinical success and mortality, but…

  8. Journal Article

    The changing epidemiology and long-term outcomes of patients with CRE infections

    Sunish Shah; Lloyd G. Clarke; Erin K. McCreary et al.

    Antimicrobial Stewardship & Healthcare Epidemiology, Vol. 6 · 2026 · English · DOAJ Scopus

    Abstract Background: The impact of organism species and underlying comorbidities on long-term clinical outcomes for patients with carbapenem-resistant Enterobacterales (CRE) infections is unknown. Methods: Patients with CRE-positive cultures from 2011 to 2019 were monitored for 1-year. Patients…

  9. Journal Article

    Real-world analysis of ceftolozane/tazobactam prescribing patterns and effectiveness: SPECTRA analysis on chronic pulmonary diseases and respiratory-related infections

    Emre Yucel; Alex Soriano; David L. Paterson et al.

    Journal of Global Antimicrobial Resistance, Vol. 44 · 2025 · English · DOAJ Scopus

    Objectives: In hospital settings, both pre-existing antibiotic-resistant Gram-negative (GN) bacteria and those that develop resistance during treatment pose significant challenges, often contributing to significant morbidity and mortality. This study focuses on chronic pulmonary disease (CPD) and…

  10. Journal Article

    Ceftolozane/tazobactam in action: Prescribing patterns, effectiveness, and healthcare utilisation across seven countries

    Emre Yucel; Alex Soriano; David L. Paterson et al.

    Journal of Global Antimicrobial Resistance, Vol. 46 · 2026 · English · DOAJ Scopus

    Objectives: Infections by antimicrobial-resistant, Gram-negative bacteria present significant global challenge, resulting in difficult treatment scenarios and poor clinical outcomes. Although ceftolozane/tazobactam (C/T) has been approved for the treatment of hospital-acquired HABP/VABP, cUTI, and…

  11. Journal Article

    Colorectal cancer screening behaviors of general surgeons and first-degree family members: a survey-based study

    Suleyman Utku Celik; Hasan Gorkem Cay; Ersin Bayrakdar et al.

    BMC Gastroenterology, Vol. 19 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background Colorectal cancer (CRC) screening rates are low in the general population and among health care providers. The aim of this study was to evaluate the CRC screening practices of general surgeons who provide specialized diagnostic testing and CRC treatment and to examine the CRC…

  12. Journal Article

    Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE)

    Walaiporn Wangchinda; Janet Y. Wu; Lilian M. Abbo et al.

    Antimicrobial Agents and Chemotherapy, Vol. 69 No. 12 · 2025 · English · DOAJ Scopus

    ABSTRACT Imipenem-relebactam demonstrates in vitro activity against multidrug-resistant (MDR) Pseudomonas aeruginosa, but real-world effectiveness data are limited. MIRAGE was a multicenter, retrospective, observational study of imipenem-relebactam for MDR P. aeruginosa pneumonia and bacteremia…